Respect - A multicenter retrospective study on preoperative chemotherapy in locally advanced and borderline resectable pancreatic cancer

Weniger M., Moir J., Damm M., Maggino L., Kordes M., Rosendahl J., ...Daha Fazla

PANCREATOLOGY, cilt.20, sa.6, ss.1131-1138, 2020 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 20 Konu: 6
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1016/j.pan.2020.06.012
  • Sayfa Sayıları: ss.1131-1138


Background: Neoadjuvant chemotherapy has become a powerful tool to convert borderline resectable (BRPC) and locally advanced pancreatic cancers (LAPC) into a resectable scenario. However, data analyzing the optimal type of therapy are scarce. In the present multicenter retrospective study, we evaluated the influence of FOLFIRINOX (FFX) and gemcitabine (GEM)-based neoadjuvant therapy on patient prognosis.